MedTrace Logo

A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice

NCT03613077 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2026-01-09

No results posted yet for this study

Summary

Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement

Conditions

  • Surgical Operation With Implant of Artificial Internal Device

Interventions

PROCEDURE

surgical placement of an endosteal implant

Subjects, male or female at least 18 years old, with the need of dental implant therapy and restoration according to the cleared indications for the implant

Sponsors & Collaborators

  • Institut Straumann AG

    lead INDUSTRY

Principal Investigators

  • Christian Walter, Prof. Dr.Dr. · Mediplus Praxisklinik

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-14
Primary Completion
2020-02-02
Completion
2025-08-21

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03613077 on ClinicalTrials.gov